New report reveals need for pricing and reimbursement and procurement reforms to ensure patient access and healthcare sustainability |
Medicines for Europe |
Mon, 03/01/2021 |
Health & Consumers |
New safeguards for patient safety as Falsified Medicines Directive comes into force |
Medicines for Europe |
Mon, 02/11/2019 |
Health & Consumers |
No further excuse to delay digital regulatory infrastructure for medicines after COVID-19 pandemic |
Medicines for Europe |
Fri, 02/19/2021 |
Health & Consumers |
Now or never: Europe must seize the Pharma Legislation opportunity to ensure patient access to continuous innovation for existing medicines |
Medicines for Europe |
Tue, 11/07/2023 |
Health & Consumers |
Now or never: pragmatism & ambition needed in EU pharma strategy to deliver on Europe’s medicines manufacturing |
Medicines for Europe |
Wed, 10/07/2020 |
Health & Consumers |
Off patent medicines essential for a fairer, healthier, and sustainable Europe says President Christoph Stoller |
Medicines for Europe |
Fri, 04/30/2021 |
Health & Consumers |
Off-patent medicines industry marks 30 years of delivering public health impact |
Medicines for Europe |
Wed, 06/12/2024 |
Health & Consumers |
Off-patent medicines ready to drive pharma policy reform for equitable access, availability and security of medicines supply |
Medicines for Europe |
Thu, 06/15/2023 |
Health & Consumers |
Oncology, the new era for biosimilar medicines |
Medicines for Europe |
Fri, 09/08/2017 |
Health & Consumers |
Open borders that prioritise essential goods key to medicines supply in Europe |
Medicines for Europe |
Wed, 06/02/2021 |
Health & Consumers |
Orphan and paediatric reform should strive to improve access to medicine for rare disease patients and children |
Medicines for Europe |
Fri, 07/30/2021 |
Health & Consumers |
Parliament compromise on pharmaceutical legislation accelerates much needed reform |
Medicines for Europe |
Tue, 03/19/2024 |
Health & Consumers |
Parliament’s balanced stand on Unitary SPC regulation rewards innovation via an efficient Unitary SPC system that protects against access to medicines delays |
Medicines for Europe |
Wed, 02/28/2024 |
InfoSociety |
Parliament’s Health Committee (ENVI) introduces constructive amendments to SPC Manufacturing waiver vote in its official opinion to the Parliament’s Legal Committee (JURI). |
Medicines for Europe |
Wed, 11/28/2018 |
Health & Consumers |
Parliament’s Trade Committee votes for jobs and access to medicines with a comprehensive SPC Manufacturing Waiver! |
Medicines for Europe |
Tue, 12/04/2018 |
Health & Consumers |
Patients should benefit from greater access under new patent package proposals |
Medicines for Europe |
Fri, 04/28/2023 |
Health & Consumers |
Pharmaceutical legislation reforms must support equitable access to medicine in Central and Eastern Europe and security of medicines supplies |
Medicines for Europe |
Thu, 11/17/2022 |
Health & Consumers |
Proposals on wastewater treatment will jeopardise patient access to medicines without helping green transition |
Medicines for Europe |
Thu, 10/27/2022 |
Health & Consumers |
Protecting health: Active generic and biosimilar policies central to EU pharmaceutical strategy |
Medicines for Europe |
Tue, 03/03/2020 |
Health & Consumers |
Reaction to EU Pharmaceutical legislation: Timely and equitable access for patients and security of supply essential for reform |
Medicines for Europe |
Thu, 04/27/2023 |
Health & Consumers |
Ready to drive access to medicines |
Medicines for Europe |
Wed, 07/24/2019 |
Health & Consumers |
Reformed incentives system promises better patient access in Europe |
Medicines for Europe |
Tue, 06/11/2024 |
Health & Consumers |
Regulatory reforms critical to improve patient access to medicines |
Medicines for Europe |
Mon, 01/24/2022 |
Health & Consumers |
Report identifies 9 key ingredients to improve access to medicines in the hospital setting |
Medicines for Europe |
Tue, 10/08/2019 |
Health & Consumers |
Report shows life sciences industry alliance is taking action to curb antimicrobial resistance, with more to come |
Medicines for Europe |
Thu, 01/18/2018 |
Health & Consumers, InfoSociety |
Repurposing: a golden opportunity for patient centric health investment in Europe |
Medicines for Europe |
Wed, 04/06/2022 |
Health & Consumers |
Risk that European Council will “neuter” SPC manufacturing waiver and give foreign (non-EU) manufacturers strong advantage over EU-based manufacturers |
Medicines for Europe |
Fri, 10/12/2018 |
Health & Consumers |
Smart Pharmacovigilance Essential for Patient Safety |
Medicines for Europe |
Wed, 01/29/2020 |
Health & Consumers |
Smart policies will encourage more critical medicines manufacturing in Europe |
Medicines for Europe |
Fri, 02/26/2021 |
Health & Consumers |
Smart reform of EU pharma and IP legislation key to boosting access to essential medicines |
Medicines for Europe |
Thu, 06/30/2022 |
Health & Consumers |